Health🇺🇸· 2 hours agoModerna, Merck melanoma vaccine clears Phase 3 trial goalWhat's next: The companies plan talks with regulators within months as they pursue approval for the personalized shot with Keytruda.#Moderna#MerckBloomberg, The New York Times +3